Anti‐DNA Ig peptides promote Treg cell activity in systemic lupus erythematosus patients

Abstract

These results suggest a new modality to reverse the functional deficit of Treg cells in SLE patients with positive autoimmune serology, and identify a new strategy to enhance immunoregulatory T cell activity in human SLE.